Nature has published their April 2022 Biopharma Dealmakers collection on the Advances in Artificial Intelligence-Driven ...
Age related medical conditions account for over 60% of all loss of human life
Selvedge Venture invests into founders and start ups with a mission to allieviate the titanic healthcare burden caused by age-related medical conditions. We invest into Pre-Seed, Seed and Series A ready companies
We focus on three age related medical conditions
Metabolic Syndrome (Cardiovascular Disease, Diabetes, Fatty Liver Disease and Obesity), Cancer and Neurodegenerative Diseases. Each of these conditions accounts for a huge burden of both excess deaths and healthcare spend
Leveraging Biotechnology, Machine Learning Tools and Integrated Data Assets
Selvedge Venture’s core expertise is at the intersection of Biotechnology and Digital Technologies. Recent advances in the state of the art of both of these technologies provide a platform to shape healthcare and life sciences for many years to come
On a journey to drastically speed up cell therapy manufacturing, Kytopen lands $30M Series A
Spun out of an MIT lab, sitting in an office space above a Cambridge tapas restaurant from world-renowned chef Ken Oring ...
London-based health startup snaps up £2M to turbocharge diagnostics development with clinically validated home testing
The complexity of health and disease cannot be captured by a singular diagnostic test and therefore can’t be expected to ...
SELECTED PORTFOLIO COMPANIES
Risk Warning
Don’t invest unless you’re prepared to lose money. This is a high‑risk investment. You may not be able to access your money easily and are unlikely to be protected if something goes wrong.